Biolog-id joins forces with LifeShare Blood Center to combat COVID-19

LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients

9 Jun 2020
Diane Li
Assistant Editor

Biolog-id, a world leader in connected solutions for blood and other high value health products, has announced that LifeShare Blood Center, a leading provider of blood products in the South Central United States, implemented Biolog-id’s RFID-enabled, data analytics solution in its blood supply chain. The deployed solution provides real-time visibility to convalescent plasma from collection to distribution, streamlining inventory, improving efficiency, and ultimately maximizing Return on Donation. Better visibility to the inventory facilitates efficient management of convalescent plasma, and so increases the availability of these scarce and valuable antibodies to the COVID-19 patients who need them.

“Biolog-id LLC has been a strategic partner to our industry, filling a gap in the timely delivery of convalescent plasma,” said Monica Kalvelage, Chief Operations Officer, of LifeShare Blood Center. “Their innovative technology automates a crucial process, enabling a more efficient inventory management and delivery of critical convalescent plasma to COVID-19 patients.”

“The ability to quickly respond to changes in market needs is key to Biolog-id,” said Amit Mayer, VP Innovation & Analytics at Biolog-id LLC. “As a team we were able to move from defining the Covid-19 convalescent plasma solution to implementing it within weeks, all in close cooperation with LifeShare.”

“Convalescent plasma presents LifeShare Blood Center with an incredible opportunity to positively impact the population they serve. Facilitating their move to a digital future on our platform has been a pleasure,” said Troy L. Hilsenroth, CEO Biolog-id LLC. “We are at an exciting time in Biolog-id's evolution as organizations continue to adopt our solutions to unlock desired operational, clinical, and financial value.

Enabling a new standard of care of how high-value products in healthcare are distributed, stored, utilized, and tracked are central to Biolog-id LLC’s vision.

Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags